These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 9615743

  • 21. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK, Davey MW, Davey RA.
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [Abstract] [Full Text] [Related]

  • 22. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
    Kelland LR, Mistry P, Abel G, Freidlos F, Loh SY, Roberts JJ, Harrap KR.
    Cancer Res; 1992 Apr 01; 52(7):1710-6. PubMed ID: 1312897
    [Abstract] [Full Text] [Related]

  • 23. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS, Nishio K, Ogasawara H, Funayama Y, Ohira T, Saijo N.
    Cancer Res; 1995 Mar 01; 55(5):1075-9. PubMed ID: 7866991
    [Abstract] [Full Text] [Related]

  • 24. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
    Mirski SE, Evans CD, Almquist KC, Slovak ML, Cole SP.
    Cancer Res; 1993 Oct 15; 53(20):4866-73. PubMed ID: 8104687
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Additive effects of amrubicin with cisplatin on human lung cancer cell lines.
    Yamauchi S, Kudoh S, Kimura T, Hirata K, Yoshikawa J.
    Osaka City Med J; 2002 Jun 15; 48(1):69-76. PubMed ID: 12375699
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
    Barret JM, Calsou P, Larsen AK, Salles B.
    Mol Pharmacol; 1994 Sep 15; 46(3):431-6. PubMed ID: 7935322
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
    Saleem A, Ibrahim N, Patel M, Li XG, Gupta E, Mendoza J, Pantazis P, Rubin EH.
    Cancer Res; 1997 Nov 15; 57(22):5100-6. PubMed ID: 9371509
    [Abstract] [Full Text] [Related]

  • 34. Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance.
    Kurokawa H, Ishida T, Nishio K, Arioka H, Sata M, Fukumoto H, Miura M, Saijo N.
    Biochem Biophys Res Commun; 1995 Nov 02; 216(1):258-64. PubMed ID: 7488097
    [Abstract] [Full Text] [Related]

  • 35. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns.
    Beketić-Oresković L, Osmak M.
    Neoplasma; 1994 Nov 02; 41(3):171-6. PubMed ID: 7935986
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6.
    Ishii M, Iwahana M, Mitsui I, Minami M, Imagawa S, Tohgo A, Ejima A.
    Anticancer Drugs; 2000 Jun 02; 11(5):353-62. PubMed ID: 10912951
    [Abstract] [Full Text] [Related]

  • 39. The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells.
    Takigawa N, Takeyama M, Shibayama T, Tada A, Kawata N, Okada C, Aoe K, Kozuki T, Hotta K, Tabata M, Kiura K, Ueoka H, Tanimoto M, Takahashi K.
    Oncol Rep; 2006 Apr 02; 15(4):837-42. PubMed ID: 16525668
    [Abstract] [Full Text] [Related]

  • 40. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W, Liu G, Zheng J.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):61-7. PubMed ID: 17509556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.